Stocks

Noxopharm Presented Highly Encouraging Veyonda® Clinical Data at ASC...

Summary Noxopharm presented two sets of clinical data concerning the development of Veyonda® as a treatment for end-stage prostate cancer at AS...

Prescient Reports March 2020 Quarterly Update; Cash Reserves at $8.2...

Australian based clinical-stage Oncology company Prescient Therapeutics Limited (ASX:PTX), recently reported operating highlights and financial outcom...

Lens over SUDA’s Operational Highlights in 1H FY20

Continuing its practice of delivering solid operational results, oro-mucosal drug delivery firm SUDA Pharmaceuticals Ltd (ASX:SUD) has recently declar...

Latest Brand Enhancements at Consumer Powerhouse-Pental Limited

A renowned ASX-listed consumer staples company producing some of the world’s most recognisable brands, Pental Limited (ASX:PTL) is a full end-to...

AuMake Ensures Contracts Will Be Met Despite Coronavirus Outbreak

The stock markets around the world have retreated with the fears prevailing around the fallout on global growth outlook due to China's coronavirus out...

Why is the THC Global share price rocketing higher?

Marijuana stocks or pot stocks are catching investors eyes these days after the legalisation of cannabis for medicinal and recreational use in many co...

A Smash Hit by Imugene: Received Core US Patent for HER-Vaxx

It’s surely a prosperous new year for the clinical-stage immuno-oncology player, Imugene Limited (ASX:IMU) that has received core US patent in t...

Emergence of new Bellamy's? Wattle Health Story

  Wattle Health Australia Limited (ASX: WHA) Wattle Health is rapidly undertaking decisions to scale up its reach and presence. The company has...

Prescient Collaborates with Carina Biotech in Expansion into Excitin...

Prescient Therapeutics Limited (ASX: PTX) develops personalised medicine approaches to address mutations that cause cancer. The Company employs a targ...

Health Care Stocks In Red Zone Today: Mayne, PolyNovo, Nanosonics

Health care sector is one of the most significant contributors to the Australian economy, known for delivering best services by advancing technology....

Online Screening and Verification Company, CVCheck’s new B2B wins Dr...

CVCheck Limited (ASX: CV1) is a young and expanding information technology company based in Australia with growing revenue streams. It provides people...

Hits & Misses for the four Major Banks – ANZ, CBA, NAB, WBC

In Australia, the banking industry is dominated by the four major banks that include Australia & New Zealand Banking Group Limited (ASX: ANZ), Com...

Are Dividend Cuts On The Cards For The Bank Stocks?

Apart from idiosyncratic headwinds towards each of the bank, there is one pervasive obstacle that the earnings of banking players might witness - woul...

Online Cyber Security Exchange, WhiteHawk Limited – Latest developme...

The first online cyber security exchange across the world, WhiteHawk Limited (ASX: WHK) is an Australian-headquartered firm allowing SMEs to take smar...

A Deep Dive into Imugene’s Opportunities in the Immuno-oncology Mark...

Imugene Limited (ASX: IMU) is a clinical stage biotechnology company that focuses on the development of immunotherapies that have the potential to ena...

Journey of Prescient Therapeutics in 2019

Prescient Therapeutics Limited (ASX: PTX) is a clinical-stage oncology company that works on mutation causing cancer. The existing product portfolio o...

Noxopharm Eyes The Development Of A Well-Tolerated ‘STING agonist’ D...

Noxopharm Limited (ASX: NOX) has released July 2019 edition of its Newsletter called 'Versatility'. The clinical-stage drug development company, Noxo...

An Overview Of IMU’s B-Cell Vaccines’ Clinical Trials

An Australian-based biotechnology company, Imugene Limited (ASX: IMU) focuses on the development of cancer immunotherapies targeted at activating the...

A Look at Imugene’s robust pipeline of B-Cell Vaccines for Cancer Im...

An Australian-headquartered clinical stage immuno-oncology company, Imugene Limited (ASX: IMU) has a robust pipeline of B cell vaccines aimed at treat...

AFP’s FY19 Performance - What investors need to know?

AFT Pharmaceuticals Limited (ASX: AFP) is a growing pharma company with its head office based out of New Zealand. It officially was listed on ASX in D...